Humacyte, Inc. (HUMA) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-27 10:55:56 ET
Humacyte, Inc. (HUMA) Q4 2025 Earnings Call March 27, 2026 8:00 AM EDT
Company Participants
Laura Niklason - Founder, President, CEO & Director
Dale Sander - CFO, Chief Corporate Development Officer & Treasurer
...
Read the full article on Seeking Alpha
For further details see:
Humacyte, Inc. (HUMA) Q4 2025 Earnings Call Transcript
Humacyte Inc. Warrant
NASDAQ: HUMAW
HUMAW Trading
-12.93% G/L:
$0.0505 Last:
960 Volume:
$0.0445 Open:
HUMAW Latest News
HUMAW Stock Data
$247,325,345
156,832,240
N/A
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
